Category: Drug Safety Alerts
-
Ozempic Vision Loss Lawsuits Have Been Filed by Patients Against Novo Nordisk
We List Some of the Legal Liability Allegations Regarding Drug Company Actions and Failures (Posted by Tom Lamb at Drug Injury Watch) During the past several weeks, Ozempic vision loss lawsuits have been filed by…
-
March 2025 Medical Article About Blindness or Vision Loss Linked to Ozempic and Rybelsus Use by Diabetes Patients
Discusses Timing for Increased Risk of Semaglutide-related Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Side Effect (Posted by Tom Lamb at Drug Injury Watch) On March 27, 2025, the JAMA Ophthalmology medical journal published a report…
-
Ozempic Vision Problems From Semaglutide Apply to Wegovy and Rybelsus, Also
NAION Eye Side Effect Risk Increased With Semaglutide Drugs – Two Recent Medical Studies (Posted by Tom Lamb at Drug Injury Watch) UPDATE: The [European Medicines Agency (EMA)] Pharmacovigilance Risk Assessment Committee (PRAC) reviewed all available…
-
Depo-Provera Drug Label Warnings in US Do Not Include Increased Risk of Intracranial Meningioma
While European Union (EU) and United Kingdom (UK) Drug Labels Have Warned About Meningioma for Many Years (Posted by Tom Lamb at Drug Injury Watch) Drug injury lawsuits that involve the contraceptive injection Depo-Provera being linked to…
-
Novo Nordisk Semaglutide Drug Ozempic Linked to Vision Loss, Doubling the Risk: December 2024 Update
European Drug Regulators Are Investigating Semaglutide-Related NAION Cases Presented in Two Danish Studies (Posted by Tom Lamb at Drug Injury Watch) According to this December 18, 2024, Reuters news report, "Novo Nordisk's Ozempic faces EU…
-
Side Effects of Birth Control: Brain Tumors Related to Depo-Provera Contraceptive Injections
Intracranial Meningioma Risks Are Increased When Depo-Provera Was Used for More Than One Year (Posted by Tom Lamb at Drug Injury Watch) See also: “Depo-Provera Drug Label Warnings in US Do Not Include Increased Risk of Intracranial…
-
Veozah Liver Injury Drug Safety Communication Issued by FDA in September 2024
August 2024 Veozah Drug Label Change Adds Warnings About Liver Toxicity and Abnormal Liver Tests (Posted by Tom Lamb at Drug Injury Watch) UPDATE: January 2025 Dear Healthcare Professional letter sent by Astellas Pharma Ltd. in…